ArticleNeurologia medico-chirurgica2025
Nationwide Brain Tumor Registry-based Study of Adult Intracranial Ependymoma in Japan.
Article in Neurologia medico-chirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ependymoma, a rare neuroepithelial malignancy of the central nervous system, affects both children and adults and may occur anywhere along the neuroaxis. This study aimed to analyze the treatment outcomes of adult intracranial ependymoma cases in Japan using data from the Brain Tumor Registry of Japan between 2001 and 2008. The dataset comprised 169 eligible patients after applying exclusion criteria, such as subependymoma and myxopapillary ependymoma cases. Patient data encompassed demographic details, tumor classification, treatment strategies, extent of resection, WHO grade, and survival outcomes.Kaplan-Meier and multivariate Cox proportional hazards analyses identified key prognostic factors influencing overall survival and progression-free survival. Gross total resection and near-total resection were associated with better outcomes, while EOR less than 95% and preoperative Karnofsky performance status score below 70 were significantly correlated with poorer OS. WHO grade 2 tumors were more prevalent in posterior fossa and demonstrated better survival outcomes than grade 3 tumors in univariate analyses. However, WHO grade did not remain significant in multivariate analysis when adjusted for tumor location.This study highlights the critical impact of radical resection on ependymoma prognosis. While CNS WHO grade showed correlations with tumor location and survival, its role in predicting outcomes remains uncertain and may depend on molecular subtypes. Updated molecular classifications are recommended for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.